Mirae Asset Global Investments’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.4K | Buy |
1,781
+325
| +22% | +$4.45K | ﹤0.01% | 1369 |
|
|
2025
Q1 | $16.3K | Buy |
1,456
+50
| +4% | +$560 | ﹤0.01% | 1406 |
|
|
2024
Q4 | $15.1K | Sell |
1,406
-117
| -8% | -$1.26K | ﹤0.01% | 1459 |
|
|
2024
Q3 | $19.6K | Buy |
1,523
+444
| +41% | +$5.73K | ﹤0.01% | 1438 |
|
|
2024
Q2 | $18.3K | Buy |
+1,079
| New | +$18.3K | ﹤0.01% | 1392 |
|
|
2024
Q1 | – | Sell |
-11,348
| Closed | -$170K | – | 2651 |
|
|
2023
Q4 | $170K | Buy |
11,348
+60
| +0.5% | +$900 | ﹤0.01% | 2369 |
|
|
2023
Q3 | $158K | Buy |
11,288
+181
| +2% | +$2.54K | ﹤0.01% | 2361 |
|
|
2023
Q2 | $115K | Buy |
+11,107
| New | +$115K | ﹤0.01% | 2474 |
|
|
2021
Q3 | – | Sell |
-363
| Closed | -$6K | – | 1783 |
|
|
2021
Q2 | $6K | Buy |
+363
| New | +$6K | ﹤0.01% | 1690 |
|